This data helps your healthcare provider make informed adjustments to your protocol, whether that means slowing escalation, adding supportive interventions, or confirming that your current dose is well-tolerated
Hashimoto's disease, an autoimmune thyroid condition affecting approximately 5% of Americans, often leads to hypothyroidism and challenging weight gain despite standard levothyroxine therapy
instead, treatment follows a step-up schedule from a low starting amount to a maintenance dose that is effective and well tolerated
In Q1 2026, Amgen announced a SWITCH study enrolling 300 patients transitioning from weekly semaglutide or tirzepatide to MariTide on less frequent schedules, positioning the drug as a potential maintenance or step-down therapy
In: International journal of sports medicine 15 (4), S
Ozempic is classed as a Glucagon-like peptide-1 receptor agonist (GLP-1RA), which is a drug that is used to treat type 2 diabetes